Industrial Competition & Cooperation: Mapping Global Intraosseous Access Needle Manufacturers

May 19, 2026

 

Driven by growing demand in emergency and critical‑care medicine, the intraosseous (IO) access device market has become a fast‑growing, technology‑concentrated niche segment within the medical device industry. According to market analyses, the global IO device market reached approximately USD 1.05 billion in 2025 and is projected to grow to USD 1.83 billion by 2034, representing a compound annual growth rate (CAGR) of 6.32%. This high‑potential blue‑ocean market is dominated by a small number of multinational enterprises with core technologies and complete solution portfolios, while regional and emerging manufacturers are continuously emerging.

  • Global Market: Giant‑Led and Stable Competitive Landscape

  • The global IO market features an oligopolistic competitive structure. Major players have built substantial competitive moats through continuous product innovation, clinical education and large‑scale mergers and acquisitions.
  • Teleflex: Undoubtedly the global leader in this field. Its Arrow EZ‑IO® powered driver system has become standard equipment for many emergency institutions owing to its ease of use, high success rate and extensive clinical data. Beyond devices, Teleflex has established a comprehensive training system to consolidate its market position by promoting standardized operating procedures.
  • PerSys Medical: A key innovator and competitor offering a full portfolio of IO products including manual, spring‑loaded mechanical and powered devices. Its products are renowned for human‑centric design and reliability, with continuous optimizations to packaging and user experience.
  • Pyng Medical: Famous for its unique FAST1 sternal intraosseous access system, providing clinicians with an important alternative to tibial and humeral access sites. The company has secured a solid position in specific niche markets.

Major healthcare groups such as BD (Becton, Dickinson and Company) and Cardinal Health also hold market shares through proprietary product lines or distribution partnerships.

The competitive strengths of these giants lie in three aspects:

Robust patent portfolios covering core technologies such as drive mechanisms and needle designs;

Comprehensive global distribution and clinical support networks;

Deep ties with academic institutions and guideline‑setting committees, enabling them to shape industry standards and training protocols.

Regional Markets and Growth Drivers

Regionally, North America holds the largest global market share (approximately 39%) supported by its advanced emergency medical system and high clinical awareness, followed closely by Europe. The Asia‑Pacific region, especially China and Japan, is emerging as the fastest‑growing market, driven by large population bases, continuously improved emergency care systems and rapidly increasing clinical acceptance of IO techniques.

Core market growth drivers include:

Strong recommendations for IO access in global cardiopulmonary resuscitation (CPR) and trauma emergency guidelines, raising its priority in clinical practice;

Population aging and rising chronic disease burden leading to increased numbers of emergency resuscitation cases;

Enhancement and standardization of emergency medical services (EMS) systems, making IO devices standard ambulance equipment;

Technological iteration: the popularization of battery‑powered drills lowering barriers to use and expanding applicable patient populations.

Opportunities and Challenges for the Chinese Market

China's IO market is undergoing rapid development. According to data from BIS Research, the Chinese intraosseous device market reached CNY 2.356 billion in 2025. Initially dominated by international brands including Teleflex and PerSys Medical, the market has opened up opportunities for domestic enterprises amid national policies encouraging medical device localization and cost‑control initiatives such as group purchasing organizations (GPO).

Several Chinese medical device firms have entered this sector, launching domestic IO puncture needles and devices via technology introduction or independent research and development. Although no domestic leader capable of fully competing with global giants has yet emerged, Chinese supply chains are gradually demonstrating cost advantages in manufacturing single‑use consumable puncture needles. Future breakthrough points for Chinese manufacturers may include:

Developing cost‑effective powered driver systems to realize domestic substitution of core equipment;

Conducting incremental product innovations tailored to Chinese clinical needs;

Penetrating grassroots markets with solutions suited to China's pre‑hospital emergency care and county‑level hospital requirements.

Product Segmentation and Competitive Focus

Market products are mainly divided into two categories: devices (powered drivers) and consumables (puncture needles). As single‑use items, consumables provide recurring revenue streams. Competition has expanded beyond pure product performance to comprehensive solution provision, including:

  • Training and education: Providing highly simulated training models (e.g., IO training legs manufactured by Shanghai Xinman Medical), simulation courses and certification systems;
  • Intelligence and data integration: Exploring connectivity between IO devices, patient monitors and electronic medical record systems;
  • Breadth and depth of product lines: Offering product portfolios covering all patient groups including neonates, children, adults and obese patients, as well as all access sites including the tibia, humerus and sternum.

Overall, the global intraosseous access needle market is a high‑value sector driven jointly by technological innovation and clinical demand. While global giants build barriers through first‑mover advantages, local players in emerging markets such as China are gathering momentum. Future competition will increasingly center on clinical value, cost‑effectiveness and localized services.

news-1-1